Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors

Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors

Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification, and processes for their preparation. The compounds are useful in the treatment of CNS disorders such as depression or anxiety.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PIZZI, DOMENICA ANTONIA, MERLO, GIANCARLO, TIBASCO, JESSICA, RINALDI, MARILISA, BERTANI, BARBARA, BERGAUER, MARKUS, BROMIDGE, STEVEN MARK, BIAGETTI, MATTEO, FALCHI, ALESSANDRO, LESLIE, COLIN PHILIP, VONG, ANTONIO KUOK KEONG, WARD, SIMON EDWARD, STASI, LUIGI PIERO
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PIZZI, DOMENICA ANTONIA
MERLO, GIANCARLO
TIBASCO, JESSICA
RINALDI, MARILISA
BERTANI, BARBARA
BERGAUER, MARKUS
BROMIDGE, STEVEN MARK
BIAGETTI, MATTEO
FALCHI, ALESSANDRO
LESLIE, COLIN PHILIP
VONG, ANTONIO KUOK KEONG
WARD, SIMON EDWARD
STASI, LUIGI PIERO
description Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification, and processes for their preparation. The compounds are useful in the treatment of CNS disorders such as depression or anxiety.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ544586A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ544586A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ544586A3</originalsourceid><addsrcrecordid>eNrjZPANLM3My8_JzEtVSMxLUSgE8hKrIPyU1KLMssSSzLLUYoWMxLLMvHSFxLS0zLzMkkqFtPwiBdOMEkPdksqCVIWi1OTUgpL8omIeBta0xJziVF4ozc0g5-Ya4uyhm1qQH59aXJCYnJqXWhLvF2VqYmJqYeZoTFABAOGCNZ4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors</title><source>esp@cenet</source><creator>PIZZI, DOMENICA ANTONIA ; MERLO, GIANCARLO ; TIBASCO, JESSICA ; RINALDI, MARILISA ; BERTANI, BARBARA ; BERGAUER, MARKUS ; BROMIDGE, STEVEN MARK ; BIAGETTI, MATTEO ; FALCHI, ALESSANDRO ; LESLIE, COLIN PHILIP ; VONG, ANTONIO KUOK KEONG ; WARD, SIMON EDWARD ; STASI, LUIGI PIERO</creator><creatorcontrib>PIZZI, DOMENICA ANTONIA ; MERLO, GIANCARLO ; TIBASCO, JESSICA ; RINALDI, MARILISA ; BERTANI, BARBARA ; BERGAUER, MARKUS ; BROMIDGE, STEVEN MARK ; BIAGETTI, MATTEO ; FALCHI, ALESSANDRO ; LESLIE, COLIN PHILIP ; VONG, ANTONIO KUOK KEONG ; WARD, SIMON EDWARD ; STASI, LUIGI PIERO</creatorcontrib><description>Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification, and processes for their preparation. The compounds are useful in the treatment of CNS disorders such as depression or anxiety.</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090531&amp;DB=EPODOC&amp;CC=NZ&amp;NR=544586A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090531&amp;DB=EPODOC&amp;CC=NZ&amp;NR=544586A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PIZZI, DOMENICA ANTONIA</creatorcontrib><creatorcontrib>MERLO, GIANCARLO</creatorcontrib><creatorcontrib>TIBASCO, JESSICA</creatorcontrib><creatorcontrib>RINALDI, MARILISA</creatorcontrib><creatorcontrib>BERTANI, BARBARA</creatorcontrib><creatorcontrib>BERGAUER, MARKUS</creatorcontrib><creatorcontrib>BROMIDGE, STEVEN MARK</creatorcontrib><creatorcontrib>BIAGETTI, MATTEO</creatorcontrib><creatorcontrib>FALCHI, ALESSANDRO</creatorcontrib><creatorcontrib>LESLIE, COLIN PHILIP</creatorcontrib><creatorcontrib>VONG, ANTONIO KUOK KEONG</creatorcontrib><creatorcontrib>WARD, SIMON EDWARD</creatorcontrib><creatorcontrib>STASI, LUIGI PIERO</creatorcontrib><title>Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors</title><description>Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification, and processes for their preparation. The compounds are useful in the treatment of CNS disorders such as depression or anxiety.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPANLM3My8_JzEtVSMxLUSgE8hKrIPyU1KLMssSSzLLUYoWMxLLMvHSFxLS0zLzMkkqFtPwiBdOMEkPdksqCVIWi1OTUgpL8omIeBta0xJziVF4ozc0g5-Ya4uyhm1qQH59aXJCYnJqXWhLvF2VqYmJqYeZoTFABAOGCNZ4</recordid><startdate>20090531</startdate><enddate>20090531</enddate><creator>PIZZI, DOMENICA ANTONIA</creator><creator>MERLO, GIANCARLO</creator><creator>TIBASCO, JESSICA</creator><creator>RINALDI, MARILISA</creator><creator>BERTANI, BARBARA</creator><creator>BERGAUER, MARKUS</creator><creator>BROMIDGE, STEVEN MARK</creator><creator>BIAGETTI, MATTEO</creator><creator>FALCHI, ALESSANDRO</creator><creator>LESLIE, COLIN PHILIP</creator><creator>VONG, ANTONIO KUOK KEONG</creator><creator>WARD, SIMON EDWARD</creator><creator>STASI, LUIGI PIERO</creator><scope>EVB</scope></search><sort><creationdate>20090531</creationdate><title>Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors</title><author>PIZZI, DOMENICA ANTONIA ; MERLO, GIANCARLO ; TIBASCO, JESSICA ; RINALDI, MARILISA ; BERTANI, BARBARA ; BERGAUER, MARKUS ; BROMIDGE, STEVEN MARK ; BIAGETTI, MATTEO ; FALCHI, ALESSANDRO ; LESLIE, COLIN PHILIP ; VONG, ANTONIO KUOK KEONG ; WARD, SIMON EDWARD ; STASI, LUIGI PIERO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ544586A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>PIZZI, DOMENICA ANTONIA</creatorcontrib><creatorcontrib>MERLO, GIANCARLO</creatorcontrib><creatorcontrib>TIBASCO, JESSICA</creatorcontrib><creatorcontrib>RINALDI, MARILISA</creatorcontrib><creatorcontrib>BERTANI, BARBARA</creatorcontrib><creatorcontrib>BERGAUER, MARKUS</creatorcontrib><creatorcontrib>BROMIDGE, STEVEN MARK</creatorcontrib><creatorcontrib>BIAGETTI, MATTEO</creatorcontrib><creatorcontrib>FALCHI, ALESSANDRO</creatorcontrib><creatorcontrib>LESLIE, COLIN PHILIP</creatorcontrib><creatorcontrib>VONG, ANTONIO KUOK KEONG</creatorcontrib><creatorcontrib>WARD, SIMON EDWARD</creatorcontrib><creatorcontrib>STASI, LUIGI PIERO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PIZZI, DOMENICA ANTONIA</au><au>MERLO, GIANCARLO</au><au>TIBASCO, JESSICA</au><au>RINALDI, MARILISA</au><au>BERTANI, BARBARA</au><au>BERGAUER, MARKUS</au><au>BROMIDGE, STEVEN MARK</au><au>BIAGETTI, MATTEO</au><au>FALCHI, ALESSANDRO</au><au>LESLIE, COLIN PHILIP</au><au>VONG, ANTONIO KUOK KEONG</au><au>WARD, SIMON EDWARD</au><au>STASI, LUIGI PIERO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors</title><date>2009-05-31</date><risdate>2009</risdate><abstract>Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification, and processes for their preparation. The compounds are useful in the treatment of CNS disorders such as depression or anxiety.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_NZ544586A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T16%3A07%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PIZZI,%20DOMENICA%20ANTONIA&rft.date=2009-05-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ544586A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true